Client Login
Pay My Bill
Services
Adherence Monitoring
Pain Management
Mental Illness
Substance Use Disorder
Chronic Disease Management
BioDetect
Novel Psychoactive Substances
2023 NPS Summary
InterACT Rx
Sports Testing
Clinical Blood Testing
Infectious Disease Testing
Clinical Resources
About Definitive Testing
Clinical Updates
Webinars
Events
Patient Impact Stories
Publications
Reference Guide
Collection Instructions
Work With Us
Current Openings
About
The Aegis Difference
Executive Leadership
Scientific and Clinical Team
Testimonials
Lab Tour
News
Contact
Client Login
Pay My Bill
Services
Adherence Monitoring
Pain Management
Mental Illness
Substance Use Disorder
Chronic Disease Management
BioDetect
Novel Psychoactive Substances
2023 NPS Summary
InterACT Rx
Sports Testing
Clinical Blood Testing
Infectious Disease Testing
Clinical Resources
About Definitive Testing
Clinical Updates
Webinars
Events
Patient Impact Stories
Publications
Reference Guide
Collection Instructions
Work With Us
Current Openings
About
The Aegis Difference
Executive Leadership
Scientific and Clinical Team
Testimonials
Lab Tour
News
Contact
Client Login
Pay My Bill
Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022
Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022
Date:
March 28, 2023
Length:
25 minutes
Sign up for the Aegis Newsletter
Δ
Close
